Macquarie Group’s Harmony Biosciences HRMY Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $4.02M | Sell |
127,275
-150,243
| -54% | -$4.75M | ﹤0.01% | 1030 |
|
|
2025
Q1 | $9.21M | Sell |
277,518
-14,032
| -5% | -$466K | 0.01% | 827 |
|
|
2024
Q4 | $10M | Sell |
291,550
-1,197
| -0.4% | -$41.2K | 0.01% | 803 |
|
|
2024
Q3 | $11.7M | Sell |
292,747
-3,133
| -1% | -$125K | 0.01% | 800 |
|
|
2024
Q2 | $8.93M | Sell |
295,880
-4,026
| -1% | -$121K | 0.01% | 836 |
|
|
2024
Q1 | $10.1M | Sell |
299,906
-275,646
| -48% | -$9.26M | 0.01% | 823 |
|
|
2023
Q4 | $18.6M | Sell |
575,552
-376,841
| -40% | -$12.2M | 0.02% | 680 |
|
|
2023
Q3 | $31.2M | Buy |
952,393
+50,865
| +6% | +$1.67M | 0.04% | 545 |
|
|
2023
Q2 | $31.7M | Buy |
901,528
+72,859
| +9% | +$2.56M | 0.04% | 556 |
|
|
2023
Q1 | $27.1M | Buy |
828,669
+126,575
| +18% | +$4.13M | 0.03% | 595 |
|
|
2022
Q4 | $38.7M | Buy |
702,094
+41,250
| +6% | +$2.27M | 0.05% | 516 |
|
|
2022
Q3 | $29.3M | Buy |
660,844
+30,633
| +5% | +$1.36M | 0.04% | 584 |
|
|
2022
Q2 | $30.7M | Buy |
630,211
+224,843
| +55% | +$11M | 0.03% | 600 |
|
|
2022
Q1 | $19.7K | Buy |
+405,368
| New | +$19.7K | 0.02% | 765 |
|